The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
93695314 9369531 4 F 2013 20160830 20130626 20160909 EXP BR-ROCHE-1239895 ROCHE 48.91 YR F Y 54.00000 KG 20160909 CN BR BR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
93695314 9369531 1 PS XOLAIR OMALIZUMAB 1 Subcutaneous 28 TO 28 DAYS UNKNOWN 103976 2 DF SOLUTION FOR INJECTION /month
93695314 9369531 2 SS XOLAIR OMALIZUMAB 1 Subcutaneous 300 MG, QMO UNKNOWN 103976 300 MG SOLUTION FOR INJECTION /month
93695314 9369531 3 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK UNKNOWN 103976 SOLUTION FOR INJECTION
93695314 9369531 4 C ALENIA (BRAZIL) BUDESONIDEFORMOTEROL FUMARATE 1 Unknown UNK, 8 TO 8 HOURS 0
93695314 9369531 5 C ALENIA (BRAZIL) BUDESONIDEFORMOTEROL FUMARATE 1 Unknown 1 DF, JET (12/12 HRS) 0 1 DF
93695314 9369531 6 C AEROLIN ALBUTEROL 1 Unknown 2 DF, 2 JETS (4 TO 4 HOURS) 0 2 DF
93695314 9369531 7 C BUDESONIDE. BUDESONIDE 1 Unknown 1 DF,12 TO 12 HOURS 0 1 DF CAPSULE
93695314 9369531 8 C BUDESONIDE. BUDESONIDE 1 Unknown 1 DF, JET 12 TO 12 HOURS 0 1 DF CAPSULE
93695314 9369531 9 C BAMIFIX BAMIFYLLINE HYDROCHLORIDE 1 Unknown 300 MG, 12 TO 12 HOURS 0 300 MG CAPSULE
93695314 9369531 10 C PREDNISONE. PREDNISONE 1 Unknown UNK UNK, QD U 0 TABLET QD
93695314 9369531 11 C PREDNISONE. PREDNISONE 1 Oral 50 MG, EVERY MORNING U 0 50 MG TABLET
93695314 9369531 12 C APRESOLINE HYDROCHLORIDE HYDRALAZINE HYDROCHLORIDE 1 Unknown UNK 0 TABLET
93695314 9369531 13 C RANITIDINE. RANITIDINE 1 Unknown 1 DF, (BEFORE SLEEP 1 TABLET) 0 1 DF TABLET
93695314 9369531 14 C NORVASC AMLODIPINE BESYLATE 1 Unknown 2 DF, (2 TABLETS) 0 2 DF TABLET
93695314 9369531 15 C ENALAPRIL ENALAPRIL 1 Unknown 10 OT, UNK 0 TABLET
93695314 9369531 16 C LASIX FUROSEMIDE 1 Unknown 40 OT, UNK 0 TABLET
93695314 9369531 17 C METFORMIN METFORMIN HYDROCHLORIDE 1 Unknown 850 OT, UNK 0 TABLET
93695314 9369531 18 C Glibenclamide GLYBURIDE 1 Unknown UNK 0
93695314 9369531 19 C LUMIGAN BIMATOPROST 1 Unknown UNK 0 TABLET
93695314 9369531 20 C FLUOXETINE FLUOXETINE HYDROCHLORIDE 1 Unknown 2 DF, UNK 0 2 DF TABLET
93695314 9369531 21 C SALBUTAMOL ALBUTEROL 1 Unknown SPORADIC 0 TABLET
93695314 9369531 22 C DIGESAN BROMOPRIDE 1 Unknown 0
93695314 9369531 23 C OMEPRAZOLE. OMEPRAZOLE 1 Unknown 0 80 MG
93695314 9369531 24 C INSULIN REGULAR INSULIN NOS 1 Unknown 0
93695314 9369531 25 C RIVOTRIL CLONAZEPAM 1 Unknown 0 2 DF TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
93695314 9369531 1 Asthma
93695314 9369531 4 Asthma
93695314 9369531 6 Product used for unknown indication
93695314 9369531 7 Asthma
93695314 9369531 9 Product used for unknown indication
93695314 9369531 10 Bronchial disorder
93695314 9369531 11 Asthma
93695314 9369531 12 Product used for unknown indication
93695314 9369531 13 Product used for unknown indication
93695314 9369531 14 Product used for unknown indication
93695314 9369531 15 Product used for unknown indication
93695314 9369531 16 Product used for unknown indication
93695314 9369531 17 Diabetes mellitus
93695314 9369531 18 Product used for unknown indication
93695314 9369531 19 Glaucoma
93695314 9369531 20 Depression
93695314 9369531 21 Asthma

Outcome of event

Event ID CASEID OUTC COD
93695314 9369531 OT
93695314 9369531 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
93695314 9369531 Abdominal pain upper
93695314 9369531 Apnoea
93695314 9369531 Asthma
93695314 9369531 Back disorder
93695314 9369531 Cataract
93695314 9369531 Diabetes mellitus
93695314 9369531 Diabetic foot
93695314 9369531 Dyskinesia oesophageal
93695314 9369531 Dyspnoea
93695314 9369531 Erysipelas
93695314 9369531 Fatigue
93695314 9369531 Fluid retention
93695314 9369531 Gait disturbance
93695314 9369531 Gastrooesophageal reflux disease
93695314 9369531 Hypertension
93695314 9369531 Insomnia
93695314 9369531 Limb injury
93695314 9369531 Malaise
93695314 9369531 Oesophagitis
93695314 9369531 Osteoarthritis
93695314 9369531 Pneumonia
93695314 9369531 Pneumonia bacterial
93695314 9369531 Pulmonary oedema
93695314 9369531 Weight increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
93695314 9369531 1 20110613 0
93695314 9369531 2 20130618 0
93695314 9369531 3 20130618 0
93695314 9369531 4 2007 0
93695314 9369531 5 2008 0
93695314 9369531 7 2007 0
93695314 9369531 8 2008 0
93695314 9369531 9 2006 0
93695314 9369531 10 2006 0
93695314 9369531 11 20060601 0
93695314 9369531 12 2011 0
93695314 9369531 13 2012 0
93695314 9369531 14 2006 0
93695314 9369531 15 2007 0
93695314 9369531 16 2007 0
93695314 9369531 17 2007 0
93695314 9369531 18 2011 0
93695314 9369531 19 2007 0
93695314 9369531 20 2006 0
93695314 9369531 21 2007 0
93695314 9369531 22 2007 0
93695314 9369531 23 2007 0
93695314 9369531 24 2012 0
93695314 9369531 25 2007 0